Literature DB >> 17956222

Thermal therapy, Part III: ablation techniques.

Riadh W Y Habash1, Rajeev Bansal, Daniel Krewski, Hafid T Alhafid.   

Abstract

Ablative treatments are gaining increasing attention as an alternative to standard surgical therapies, especially for patients with contraindication or those who refuse open surgery. Thermal ablation is used in clinical applications mainly for treating heart arrhythmias, benign prostate hyperplasia, and nonoperable liver tumors; there is also increasing application to other organ sites, including the kidney, lung, and brain. Potential benefits of thermal ablation include reduced morbidity and mortality in comparison with standard surgical resection and the ability to treat nonsurgical patients. The purpose of this review is to outline and discuss the engineering principles and biological responses by which thermal ablation techniques can provide elevation of temperature in organs within the human body. Because of the individual problems associated with each type of treatment, a wide range of ablation techniques have evolved including cryoablation as well as ultrasound, radiofrequency (RF), microwave, and laser ablation. Aspects of each ablation technique, including mechanisms of action, equipment required, selection of eligible patients, treatment techniques, and patient outcomes are presented, along with a discussion of limitations of the techniques and future research directions.

Entities:  

Mesh:

Year:  2007        PMID: 17956222     DOI: 10.1615/critrevbiomedeng.v35.i1-2.20

Source DB:  PubMed          Journal:  Crit Rev Biomed Eng        ISSN: 0278-940X


  14 in total

Review 1.  Image-guided thermal ablation with MR-based thermometry.

Authors:  Mingming Zhu; Ziqi Sun; Chin K Ng
Journal:  Quant Imaging Med Surg       Date:  2017-06

2.  Theoretical modeling for hepatic microwave ablation.

Authors:  Punit Prakash
Journal:  Open Biomed Eng J       Date:  2010-02-04

3.  Randomized controlled study between suture ligation and radio wave ablation and suture ligation of grade III symptomatic hemorrhoidal disease.

Authors:  P J Gupta; P S Heda; S Kalaskar
Journal:  Int J Colorectal Dis       Date:  2008-09-07       Impact factor: 2.571

4.  Percutaneous cryoablation of symptomatic venous malformations as a second-line therapeutic option: a five-year single institution experience.

Authors:  F H Cornelis; F Marin; C Labrèze; V Pinsolle; Y Le Bras; D Midy; N Grenier
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

5.  Modeling focused ultrasound exposure for the optimal control of thermal dose distribution.

Authors:  E Sassaroli; K C P Li; B E O'Neill
Journal:  ScientificWorldJournal       Date:  2012-04-19

Review 6.  Physical mechanism and modeling of heat generation and transfer in magnetic fluid hyperthermia through Néelian and Brownian relaxation: a review.

Authors:  E Y K Ng; S D Kumar
Journal:  Biomed Eng Online       Date:  2017-03-23       Impact factor: 2.819

7.  Preliminary experience in the management of brain and skull-base tumors with microwave ablation; feasibility guided by ultrasound, report from 23 cases.

Authors:  Adrián Santana Ramírez; Pedro Ávila Rodríguez; Sergio Valente Esparza Gutiérrez; Oscar Gutiérrez Ávila
Journal:  Surg Neurol Int       Date:  2019-02-08

8.  The Ultrasmall Biocompatible CuS@BSA Nanoparticle and Its Photothermal Effects.

Authors:  Xiaofang Wan; Maixian Liu; Mingze Ma; Danyang Chen; Na Wu; Li Li; Zhongjun Li; Guimiao Lin; Xiaomei Wang; Gaixia Xu
Journal:  Front Pharmacol       Date:  2019-02-26       Impact factor: 5.810

Review 9.  Recent Advances in Cyanine-Based Phototherapy Agents.

Authors:  Kubra Bilici; Sultan Cetin; Eda Aydındogan; Havva Yagci Acar; Safacan Kolemen
Journal:  Front Chem       Date:  2021-06-24       Impact factor: 5.221

10.  High-Frequency Irreversible Electroporation for Intracranial Meningioma: A Feasibility Study in a Spontaneous Canine Tumor Model.

Authors:  Eduardo L Latouche; Christopher B Arena; Jill W Ivey; Paulo A Garcia; Theresa E Pancotto; Noah Pavlisko; Scott S Verbridge; Rafael V Davalos; John H Rossmeisl
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.